Staff ReportsThe British Medical Association’s sudden change of heart on the Cass Review is the kind of surprise that makes you check the calendar twice. After months of hot takes and defensive hand-wringing from the medical establishment, the BMA — which once dismissed the review’s findings — now says it can’t find a single recommendation in the Cass Report it opposes. That matters. A lot.
The BMA’s U-turn: what actually happened
The Cass Review, led by Dr. Hilary Cass, warned that NHS gender services for children were operating on thin evidence and urged “extreme caution” when it came to puberty blockers and cross-sex hormones. Published after careful review, the report called for clearer clinical reasoning and more research before rushing into life-altering treatments for minors. The BMA’s board of science chair, Professor David Strain, has now praised that approach and signaled agreement with most of the review’s 32 recommendations. That’s a big reversal from earlier resistance.
Why this matters beyond the NHS
Don’t kid yourself — this isn’t just a British squabble. The Cass Review has been used in legal and policy debates on both sides of the Atlantic. When a major doctors’ body like the BMA moves toward evidence-based caution, it gives lawmakers, judges, and parents stronger grounds to demand limits on experimental medical interventions for children. Activists who pushed full-throttle medical pathways for minors are losing the “expert consensus” card they once waved around. If anyone thought medical orthodoxy was immutable, today’s twist proves otherwise.
Protecting children isn’t radical — it’s common sense
There’s nothing cruel about saying minors should pause before taking drugs and undergoing surgeries that change their bodies forever. You have to be 18 to get a tattoo in most places. You should at least wait until adulthood before permanent medical interventions that carry lifelong consequences. The debate should be about safety, consent, and solid evidence — not ideology. Doctors should be gatekeepers of sound medicine, not promoters of experiment-first policies for kids.
The BMA’s shift is a welcome step back toward sanity, but it isn’t the end of the story. The association still leaves room for clinicians to prescribe hormones in some circumstances, which means the fight for clear rules, stronger research, and age limits continues. Conservatives and parents should welcome this change while pushing for firmer protections. If common sense and science win out, that will be the best news for kids and families — and for medicine itself.
